Roots Analysis

Roots Analysis provide business research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis covering the following parameters:

•Technology evolution
•Research and development
•Existing market landscape
•Future Commercial potential
•Regulatory concerns
•Regional growth drivers
•Risks and opportunities

Roots Analysis

List of reports from Roots Analysis

< prev 1    3  
Dendritic Cell and Tumor Cell Cancer Vaccines Market, 2016-2030
9/30/2016 | published by: Roots Analysis
... relapse. In 2016, an estimated 1.7 million new cancer cases were reported in the US alone. Furthermore, as projected by the World Health Organization (WHO), the annual incidence of cancer worldwide is expected to rise ...  |  read more...
USD 2,349
Smart Wearables in Healthcare, 2016-2030
9/8/2016 | published by: Roots Analysis
... ever increasing global population that currently stands at 7.4 billion, healthcare management is a primary challenge as more and more people become aware about fitness and health. In order to address this challenge, the industry ...  |  read more...
USD 2,349
Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026
8/26/2016 | published by: Roots Analysis
... in intraocular pressure (IOP). Acutely elevated IOP, a condition broadly known as ocular hypertension, may either lead to the expulsion of ocular contents through a traumatic opening or result in a number of clinical conditions ...  |  read more...
USD 2,349
HDAC Inhibitors Market, 2016 - 2026
8/19/2016 | published by: Roots Analysis
... can be modulated primarily include histone modification, DNA methylation, alteration of chromatin architecture and involvement of small-interfering or non-coding RNAs. Enzymes such as histone acetyltransferases (HATs), histone methyltransferases (HMTs), histone deacetylases (HDACs) and histone demethylases ...  |  read more...
USD 2,349
Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026
8/11/2016 | published by: Roots Analysis
... the US. The increasing incidence, growing prevalence and the progressive nature of the disease has spurred several pharmaceutical companies to develop novel approaches / therapies to provide better treatment options for diabetic patients worldwide. While ...  |  read more...
USD 2,349
Immune Checkpoint Inhibitors: Clinical Trial Tracker
7/21/2016 | published by: Roots Analysis
... checkpoints are molecules that regulate (stimulate or inactivate) the immune cells. Yervoy (an anti CTLA-4 inhibitor) was the first immune checkpoint inhibitor that was made commercially available in 2011 for treatment of patients suffering from ...  |  read more...
USD 949
T-cell Immunotherapy: Clinical Trial Tracker
7/11/2016 | published by: Roots Analysis
... promising therapeutic strategies, developed under the banner of T-cell immunotherapies, are set to hit the market in the near future. T-cells, also named as the soldiers of the immune system, are featured with specificity and ...  |  read more...
USD 949
Vaccine Contract Manufacturing Market, 2016 - 2026
6/29/2016 | published by: Roots Analysis
... standards, have limited competition among vaccine manufacturers. In addition, these complexities have also restricted innovation in this space to a great extent. However, recent advances in biotechnology and biomanufacturing have resulted in the development of ...  |  read more...
USD 2,349
Dendrimers and Polymer Drug Conjugates Market, 2016 - 2026
6/15/2016 | published by: Roots Analysis
... that help in the diagnosis, treatment and monitoring of therapeutic agents. The discovery of several nanocarriers such as polymers, proteins, micelles, dendrimers, liposomes, emulsions, nanoparticles, each with a unique structure, has provided the drug developers ...  |  read more...
USD 2,349
DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026
5/23/2016 | published by: Roots Analysis
... However, DNA is not inert. Cells are continuously exposed to several endogenous and exogenous insults that often cause DNA damage. Despite its role in cellular signalling, ROS, a by-product of mitochondrial respiration, is known to ...  |  read more...
USD 2,349
Global Autoinjectors Market, 2016 - 2026
5/11/2016 | published by: Roots Analysis
... to conventional delivery systems, these devices automate the process of delivering drugs through subcutaneous or intramuscular routes. Autoinjectors are primarily spring-driven systems and use fillable / prefilled syringes or cartridges as primary containers. Due to ...  |  read more...
USD 2,349
CD19 Therapeutics Market, 2016 - 2030
3/31/2016 | published by: Roots Analysis
... an immune response. Immunotherapies exploit the body's innate potential to specifically target a particular molecular antigen and mount an efficient immune response against the cells bearing the diseased signature. Currently, four major types of immunotherapies ...  |  read more...
USD 2,199
Fc Protein and Glycoengineered Antibodies Market (2nd Edition), 2016 - 2026
3/31/2016 | published by: Roots Analysis
... The Y-arm of the antibody is known as Fab, comprising a constant and a variable domain from each light and heavy chain. The variable domain (Fv) within the Fab region is responsible for target specificity ...  |  read more...
USD 2,199
HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026
3/9/2016 | published by: Roots Analysis
... the key focus of researchers and manufacturers worldwide. HPAPIs, which include cytotoxic APIs, are drug substances that are formulated to manufacture high potency drug products. Cytotoxic drugs are a category of highly potent drug products ...  |  read more...
USD 2,199
Speciality CROs Market, 2016-2025
2/11/2016 | published by: Roots Analysis
... overcome the shortcomings of full service / traditional CROs. Often, these full service providers offer a wider portfolio of services but fail to align their efforts to meet the requirements of sponsors, primarily the smaller ...  |  read more...
USD 2,199
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025
2/8/2016 | published by: Roots Analysis
... smaller in size and can be easily synthesized, optimized and evaluated as viable therapeutic solutions for a number of diseases. These highly favourable and intrinsic characteristics of peptides have caused an evident shift in the ...  |  read more...
USD 2,199
Microbiome Therapeutics Market, 2015 - 2030
1/15/2016 | published by: Roots Analysis
... is involved in various functions that are essential to lead a healthy life. Majority of the microorganisms benefit humans by supplementing them with traits that they would otherwise not possess. These include metabolism of complex ...  |  read more...
USD 2,199
Antibody Drug Conjugates Market 3rd Edition, 2015 - 2025
12/3/2015 | published by: Roots Analysis
... with respect to technology, although the individual molecules that form ADCs have been used since long. This new class of therapeutics has witnessed a strong acceptance from both big and small pharmaceutical companies as they ...  |  read more...
USD 2,199
RNAi Therapeutics Market, 2015 - 2030
12/1/2015 | published by: Roots Analysis
... involving short strands of nucleic acids. It is a regulatory process that cells utilise to silence and/or inhibit gene expression through the destruction of specific mRNA molecules. One of the major advantages of RNAi is ...  |  read more...
USD 2,199
Infusion Pumps Market 2015 - 2025
12/1/2015 | published by: Roots Analysis
... features and ergonomic design. The market has a wide array of different types of infusion pumps (volumetric, syringe, implantable, elastomeric, ambulatory and others); combined, they offer a large range of infusion volume, flow rate, occlusion ...  |  read more...
USD 2,199
Biotherapeutics: Novel Formulation and Delivery Approaches Focus on Antibodies and Proteins 2015 - 2025
11/10/2015 | published by: Roots Analysis
... treatment of chronic diseases and also result in high profit margins for the drug developers. There are several therapeutic areas for which biopharmaceuticals are being investigated; these include oncology, metabolic disorders, viral infections, genetic disorders ...  |  read more...
USD 2,199
Non-Invasive Cancer Diagnostics Market 2015-2030
10/20/2015 | published by: Roots Analysis
... satisfying the unmet market need for advanced and efficient treatment interventions, cancer prevention, early detection and management is extremely important. The high cancer mortality rate is primarily due to delay in detection of the disease. ...  |  read more...
USD 2,199
T-Cell Immunotherapy Market 2015-2030
10/13/2015 | published by: Roots Analysis
... each year. Although cancer therapeutics continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. Specifically, immuno-oncology has been gradually nurtured by researchers over ...  |  read more...
USD 2,200
NASH Drugs Market 2015-2025
9/3/2015 | published by: Roots Analysis
... defined as significant steatohepatitis not caused due to alcohol, drugs, toxins, infectious agents or other identifiable exogenous causes. NASH is often accompanied with a high possibility of cirrhosis, a condition in which the liver functions ...  |  read more...
USD 2,199
ADC Contract Manufacturing Market (2nd edition), 2015-2025
8/10/2015 | published by: Roots Analysis
... be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. In-house manufacturing of ADCs is rare primarily because of the ...  |  read more...
USD 2,199
< prev 1    3  
US: 800.298.5699
Int'l: +1.240.747.3093
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!